Taubman Institute Grant Programs

Rajesh Rao MD in his University of Michigan biomedical science lab, holding a test tube in a gloved hand

Accelerating New Therapies and Technology

Taubman Institute funding and project management support is extended through different levels of grants, which are awarded after consultation among the director, managing director, executive committee and the institute’s external Scientific Advisory Board.  They include:

               The Taubman Emerging Scholar Program:   Accelerating the research programs of outstanding individual early-career clinician-scientists

               Taubman Institute Innovation Projects:  Supporting multi-disciplinary team science focused on the use of clinical data 

               Taubman Technology Projects:  Providing a boost to a select cohort of non-physician researchers working on extraordinary tools that can enhance biomedical discovery at U-M and beyond.

To date, the institute has supported more than 60 individual clinician-investigators.  Collectively, they are responsible for initiating more than 100 human clinical trials of new therapies and treatments, and have published thousands of peer-reviewed papers in the most prestigious journals.

A key mission of our founding philanthropist, the late A. Alfred Taubman, was to provide financial and other support to promising research programs in order to bridge the gap between brilliant ideas and the body of work necessary to secure traditional grants.   

Since 2017 alone, Taubman-supported projects have generated more than $60 million in external funding from the NIH, pharmaceutical companies and foundations.